WallStSmart

Garden Stage Limited Ordinary Shares (GSIW)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 1074575% more annual revenue ($77.83B vs $7.24M). MS leads profitability with a 25.9% profit margin vs -191.1%. MS earns a higher WallStSmart Score of 75/100 (B).

GSIW

Avoid

23

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.11

MS

Strong Buy

75

out of 100

Grade: B

Growth: 9.3Profit: 8.0Value: 5.7Quality: 3.5
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GSIW1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

MS6 strengths · Avg: 9.2/10
Market CapQuality
$336.70B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
41.6%10/10

Strong operational efficiency at 41.6%

EPS GrowthGrowth
62.4%10/10

Earnings expanding 62.4% YoY

Profit MarginProfitability
25.9%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
28.0%8/10

Revenue surging 28.0% year-over-year

Areas to Watch

GSIW4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$24.86M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-49.7%2/10

ROE of -49.7% — below average capital efficiency

Revenue GrowthGrowth
-17.9%2/10

Revenue declined 17.9%

MS4 concerns · Avg: 2.3/10
PEG RatioValuation
1.874/10

Expensive relative to growth rate

Free Cash FlowQuality
$-3.57B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
4.751/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GSIW

The strongest argument for GSIW centers on Debt/Equity.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 25.9% and operating margin at 41.6%. Revenue growth of 28.0% demonstrates continued momentum.

Bear Case : GSIW

The primary concerns for GSIW are EPS Growth, Market Cap, Return on Equity.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.75 is elevated, increasing financial risk.

Key Dynamics to Monitor

GSIW profiles as a turnaround stock while MS is a growth play — different risk/reward profiles.

GSIW carries more volatility with a beta of 4.04 — expect wider price swings.

MS is growing revenue faster at 28.0% — sustainability is the question.

GSIW generates stronger free cash flow (-926,340), providing more financial flexibility.

Bottom Line

MS scores higher overall (75/100 vs 23/100), backed by strong 25.9% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Garden Stage Limited Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Garden Stage Limited Ordinary Shares (GSIW) stands at the forefront of the sustainable gardening and horticulture industry, offering a diverse range of eco-friendly products designed for both amateur and professional gardeners. The company is dedicated to promoting resource management and organic practices, aligning its strategies with the increasing global demand for sustainability. With a strong emphasis on research and development, GSIW utilizes cutting-edge technologies to differentiate itself in a competitive landscape. As consumer preferences shift towards environmentally responsible solutions, GSIW presents a compelling investment opportunity for institutional investors looking to diversify their portfolios with sustainable assets.

Visit Website →

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?